Agenda

Pearls for hitting the spherical target, correcting astigmatism, and enhancing the refractive outcome postoperatively. Topics include biometry, IOL formulae, posterior corneal astigmatism, toric IOL calculators, astigmatic keratotomy (manual and femto), intraoperative aberrometry, digital axis alignment, and strategies for post-refractive and challenging eyes.

Practical pearls and pitfalls for implanting different refractive IOLs (toric monofocal, trifocal/multifocal, EDOF, adjustable IOLs, and mixing IOLs). This section will cover FDA approved IOLs.

Preoperative diagnostic essentials, ocular surface evaluation and optimization, patient lifestyle assessment, and determining the best individual refractive IOL choice. Includes IOL selection for post-refractive eyes, and eyes with ocular co-morbidities.

How to establish or enhance a refractive IOL practice and how to improve communication efficacy. Panelists can share how they explain refractive concepts and expectations.
• Pre-consult and pre-operative patient education
• Setting appropriate expectations
• Communication pearls for effective and efficient patient education
• Discussing costs and value proposition
• Effective post-op counseling

Tips for office workflow and organization that are specific to the evaluation and counseling of a refractive IOL patient. Includes pearls for “customer service”, marketing, role of office staff, and discussing handling/fees.

How to manage an unhappy refractive IOL patient and any refractive or surgical complications. Includes refractive enhancement, managing toric IOL rotation, IOL exchange, and capsular complications with premium IOL patients. Communication skills and helpful dialogue will be emphasized.

Non-IOL technologies are important adjuncts to a refractive cataract practice. Topics include office diagnostic testing, femtosecond laser, Zepto PPC, new microscope features, dropless cataract surgery, and sustained release drug delivery technology.

Case studies for faculty panel, and polling to engage the audience. Topics include which refractive IOL to use in a variety of controversial situations (post-refractive, mild drusen, mild glaucoma, pilots, etc), management of dissatisfaction with halos or refractive outcome.

2021 will likely see approval of several new refractive IOLs, and potential pharmacologic approaches to presbyopia that can be an adjunct for pseudophakic patients. Immediately sequential bilateral cataract surgery is an emerging trend in the COVID era. What are the refractive issues with this approach? Finally, this session will include updates on new presbyopia correcting IOLs, accommodating IOLs, and refractive index shaping.